Introducción. Las malformaciones linfáticas quísticas, también llamadas linfangiomas quísticos, aparecen muy raramente de forma aislada en el hígado. Casos clínicos. Se presentan dos pacientes femeninas de edad preescolar con marcada hepatomegalia, dependiente de lesiones quísticas multitabicadas, secundarias a malformación linfática quística gigante del hígado, que fueron tratadas en el Hospital Pediátrico Universitario William Soler, La Habana, Cuba. Resultados. En ambos casos el diagnóstico se apoyó en los estudios de imágenes, la laparoscopia y el análisis histopatológico. En un caso el tratamiento fue la hepatectomía derecha, mientras que en el otro se empleó la escleroterapia, ambas con evolución favorable. Conclusión. A pesar de su rareza, este diagnóstico no debe obviarse ante un paciente pediátrico con lesiones hepáticas quísticas. El tratamiento de elección es la resección quirúrgica, pero su indicación y envergadura debe valorarse de forma individualizada
Introduction. Cystic lymphatic malformations, also called cystic lymphangiomas, are very rarely found in the liver. Clinical cases. Two pediatric female preschool-age patients. presented with hepatomegaly due to multi-septated cystic lesions of the liver, who received treatment at Hospital Pediátrico Universitario William Soler, La Habana, Cuba. Results. We report two pediatric cases with giant cystic lymphatic malformation of the liver. In both cases, the diagnosis were based on imaging, laparoscopy and pathology. In one case the treatment was right hepatectomy, whereas in the other, sclerotherapy was performed, both with a favorable outcome. Conclusion. Despite its rarity, this diagnosis should be considered in pediatric patients with hepatic cystic lesions. The recommended treatment is surgical resection, but its indication and extent should be assessed individually for each patient.
Humans , Sclerotherapy , Lymphangioma, Cystic , Lymphatic Abnormalities , Laparoscopy , Hepatectomy , Hepatomegaly
Introducción: los linfoceles son una complicación poco frecuente en cirugía vascular, pero pueden representarun gran riesgo en pacientes con material protésico. Caso clínico: presentamos el caso de un varón de 82 años sometido hace 43 a radioterapia por un linfoma noHodgkin que presenta un gran linfocele en contacto con material protésico tras una intervención de revasculari-zación urgente. Se realiza tratamiento escleroterápico con espuma de polidocanol al 3% sin conseguir resultadosatisfactorio, por lo que se decide la sustitución del material protésico por autólogo y mioplastia de sartorio. Discusión: a pesar del fracaso con la escleroterapia de la cavidad, en gran medida debido al gran bloqueo linfáti-co crónico, consideramos esta opción la de elección en casos de linfocele por su baja complejidad, invasividad yexcelente relación riesgo/beneficio.(AU)
Background: lymphoceles are a rare complication in vascular surgery but can represent a great risk in patientswith prosthetic material. Case report: we present the case of an 82-year-old man who underwent radiotherapy 43 years ago for non-Hodg-kin lymphoma who presented a large lymphocele in contact with prosthetic material after an urgent revasculari-zation. Sclerotherapy treatment with 3% polidocanol foam was performed without achieving satisfactory resultsfor what we chose replace the prosthetic with autologous material and sartorius myoplasty. Discussion: despite the failure with sclerotherapy of the cavity, largely due to the great chronic lymphatic blockage,we consider this option the choice in cases of lymphocele due to its low complexity, invasiveness and excellentrisk/benefit ratio..(AU)
Humans , Male , Aged , Ischemia/drug therapy , Ischemia/therapy , Lymphocele , Sclerotherapy , Prosthesis-Related Infections , Lymphoma, Non-Hodgkin , Inpatients , Physical Examination , Radiotherapy
Abstract Objective: To investigate the efficacy of 24-h interval multiple-session ethanol sclerotherapy for the treatment of simple renal cysts. Materials and Methods: The study sample included 58 patients (mean age, 65.37 ± 11.95 years). We included 76 simple renal cysts that were treated with percutaneous aspiration with a minimum of two sessions of 95% ethanol sclerotherapy in a 24-h interval between sessions. Patients were evaluated at 1, 3, and 6 months after the intervention for the efficacy of the treatment. Treatment success was defined as a complete regression of a cyst or a > 50% reduction in its volume, with no recurrence of symptoms. Results: The mean preprocedural cyst size was 72.98 ± 25.14 mm, and the mean preprocedural cyst volume was 205.76 ± 244.15 mL. The mean volume of ethanol used in the first sclerotherapy session was 62.76 ± 30.71 mL. The mean fluid accumulation in the cysts at the end of the first 24-h interval was 4.66 ± 7.13 mL. The mean quantity of ethanol used in the second sclerotherapy session was 26.48 ± 22.2 mL. A third sclerotherapy session was required in only 10 (13.2%) of the cysts. The mean follow-up period was 52.84 ± 37.83 months. The rate of complete regression was 97.4% for the whole sample at the end of the follow-up. Conclusion: Ethanol ablation with 24-h intervals is a safe and effective treatment option in the minimally invasive percutaneous treatment of simple renal cysts.
Resumo Objetivo: Demonstrar a eficácia da escleroterapia com etanol em sessões múltiplas em intervalos de 24 horas no tratamento de cistos renais simples. Materiais e Métodos: Foram avaliados 76 cistos renais simples de 58 pacientes (média de idade: 65,37 ± 11,95 anos) submetidos a aspiração percutânea e ao menos duas sessões de escleroterapia com etanol 95% num intervalo de 24 horas. Considerou- se sucesso de tratamento a regressão completa ou uma redução > 50% do volume do cisto, sem recorrência dos sintomas. Os pacientes foram reavaliados 1, 3 e 6 meses após o procedimento. Resultados: Antes do procedimento, a média do tamanho dos cistos foi de 72,98 ± 25,14 mm e a média do volume dos cistos foi de 205,76 ± 244,15 mL. A quantidade média de etanol utilizada na primeira sessão de escleroterapia foi de 62,76 ± 30,71 mL. A média de acúmulo de líquido ao final do intervalo de 24 horas foi de 4,66 ± 7,13 mL, sendo utilizada uma média de quantidade de etanol de 26,48 ± 22,2 mL na segunda sessão de escleroterapia. Uma terceira sessão de escleroterapia foi necessária em apenas 10 (13,2%) dos cistos. Na amostra geral, a taxa de regressão completa foi de 97,4%. O tempo médio de seguimento foi de 52,84 ± 37,83 meses. Conclusão: A ablação com etanol em intervalo de 24 horas é uma opção de tratamento segura, eficaz e minimamente invasiva no tratamento percutâneo de cistos renais simples.
Abstract Objective To evaluate the efficacy of hypertonic saline infiltration as a sclerosing agent in the dorsal synovial cyst of the wrist. Method Patients of both genders, aged 18 years or older, with clinical and ultrasound diagnosis of synovial cyst, and without any previous treatment were selected. Case series in which 50 patients underwent aspiration of the contents of the cyst and infiltration of the hypertonic saline solution (2 ml sodium chloride solution 20% and 1 ml of lidocaine 2%). The patients were followed up for 24 weeks, when the parameters pain, strength, range of motion, function (quickDASH and Brief Michigan question), recurrence, and complications were evaluated. Results A total of 46 patients were evaluated for 24 weeks, 18 (39.1%) cysts evolved to resolution, and 28 (60.9%) presented recurrence. There was no statistically significant difference in the effect force or in the range of motion. There was no clinically significant difference in the scores of the questionnaires. The most frequent complications were pain and edema. Conclusion Infiltration with hypertonic saline solution for the treatment of dorsal synovial cyst of the wrist showed a recurrence rate of 60.9%.
Resumo Objetivo Avaliar a eficácia da infiltração da solução salina hipertônica como agente esclerosante no cisto sinovial dorsal do punho. Método Pacientes de ambos os sexos, com 18 anos ou mais, com diagnóstico clínico e ultrassonográfico de cisto sinovial, e sem nenhum tratamento prévio foram selectionados. Série de casos em que 50 pacientes foram submetidos a aspiração do conteúdo do cisto e infiltração da solução salina hipertônica (2 ml solução de cloreto de sódio 20% e 1 ml de lidocaína 2%). Seguimento realizado por 24 semanas, durante as quais foram avaliados os parâmetros dor, força, arco de movimento, função (questionários quick disabilities of the arm, hand, and shoulder [quickDASH] e brief Michigan), recorrência e complicações. ResultadoForam avaliados 46 pacientes por 24 semanas, 18 (39,1%) cistos evoluíram para cura e 28 (60,9%) cistos apresentaram recorrência. Não houve diferença estatisticamente significante nos quesitos força e arco de movimento. Não houve diferença clinicamente significante nos escores dos questionários. As complicações mais frequentes foram dor e edema. Conclusão A infiltração com solução salina hipertônica para tratamento do cisto sinovial dorsal do punho mostrou taxa de recorrência de 60,9%.
Humans , Male , Female , Synovial Cyst/therapy
El endometrioma ovárico es un quiste con tejido endometrial ectópico que se asocia a disminución de la reserva ovárica, siendo su manejo en infertilidad controversial. Presentamos el caso de una mujer de 32 años con reserva ovárica disminuida y endometrioma mayor de 100 mm. Fue sometida a aspiración transvaginal ecoguiada y a escleroterapia con etanol, lográndose reducción del tamaño en 65% a los tres meses. Posteriormente se realizó fecundación in vitro (FIV), consiguiéndose embarazo. La exéresis del endometrioma es controversial, debido a que reduce la reserva ovárica. La escleroterapia demuestra conservarla, se asocia a una tasa baja de recurrencia y facilita la accesibilidad ovárica. La escleroterapia con etanol del endometrioma es una técnica ambulatoria, segura y eficaz que permite el embarazo en mujeres con infertilidad.
Ovarian endometrioma is a cyst with ectopic endometrial tissue associated with decreased ovarian reserve. Its management in infertility is controversial. We present the case of a 32-year-old woman with decreased ovarian reserve and endometrioma larger than 100 mm. She underwent ultrasound-guided transvaginal aspiration and subsequent sclerotherapy with ethanol, achieving a 65% reduction in size after three months. Subsequently, in vitro fertilization (IVF) was performed, and pregnancy was achieved. The excision of the endometrioma is controversial because it reduces the ovarian reserve. Sclerotherapy has been shown to preserve ovarian reserve, is associated with a low recurrence rate and facilitates ovarian accessibility. Ethanol sclerotherapy of endometrioma is a safe and effective outpatient technique that allows pregnancy in women with infertility.
As úlceras, também conhecidas como feridas, são danos superficiais ao tecido cutâneo ou mucoso. As ulcerações são denominadas crônicas quando, após determinado período, não apresentam resolução. Lesões ulceradas que afetam os membros inferiores podem apresentar diversas etiologias, desde doenças infectocontagiosas, neoplásicas, inflamatórias até vasculares. Assim, este é um relato de caso sobre uma usuária do Sistema Único de Saúde (SUS) com úlcera venosa crônica que, após diversas experiências negativas de tratamento, foi submetida a procedimento sistematizado a partir da Atenção Primária à Saúde (APS) da cidade de Morro do Chapéu (BA). No município, verificou-se a prevalência de casos de úlceras venosas crônicas sem resolutividade acompanhados na APS. No entanto, em 2018, a partir da iniciativa de uma equipe da APS, foi estabelecido um fluxo de atendimento primário e secundário no intuito de tratar com eficácia as úlceras venosas, associando medidas farmacológicas e terapia de compressão e, nos casos mais graves, a escleroterapia. Assim, por meio de atendimento humanizado visando restaurar a qualidade de vida da população, foi possível recuperar os indivíduos de lesões crônicas.
Ulcers, commonly known as sores, are superficial damage to skin or mucosal tissue. Ulcerations are classified as chronic when they do not heal after a certain period. Lower limb ulcers can have different etiologies, from infectious, neoplastic, inflammatory to vascular diseases. Thus, this experience report discusses the case of a Unified Health System (SUS) user with chronic venous ulcer who, after several negative treatment experiences, underwent systematized treatment at the Primary Health Care (PHC) of the municipality of Morro do Chapéu, Bahia, Brazil. The municipality had a prevalence of cases of unresolved conical venous ulcers managed by PHC. But in 2018, a PHC team established a flow of primary and secondary care to effectively treat venous ulcers by associating pharmacological measures and compression therapy and, for severe cases, sclerotherapy. Thus, through humanized care aimed at restoring the population's quality of life, it was possible to recover individuals from chronic injuries.
Las úlceras que también se conocen como llagas son daños superficiales en la piel o la membrana mucosa. Las ulceraciones se denominan crónicas cuando después de cierto tiempo no se resuelven. Las lesiones ulceradas, que afectan a los miembros inferiores, pueden tener diferentes etiologías, como enfermedades infecciosas, neoplásicas, inflamatorias y vasculares. Así, este estudio es un reporte de caso de una usuaria del Sistema Único de Salud (SUS) con úlcera venosa crónica que, después de varias experiencias negativas de tratamiento, fue sometida a un tratamiento sistematizado de la Atención Primaria de Salud (APS) del municipio de Morro do Chapéu, en Bahía (Brasil). En la ciudad, hubo prevalencia de casos de úlceras venosas crónicas sin resolución seguidas por la APS. Sin embargo, en 2018, a partir de la iniciativa de un equipo de APS, se estableció un flujo de atención primaria y secundaria para tratar eficazmente las úlceras venosas que asociaban medidas farmacológicas con terapia compresiva y, en los casos más graves, escleroterapia. Así, por medio de la atención humanizada dirigida a restaurar la calidad de vida de la población, fue posible recuperar a individuos con lesiones crónicas.
Humans
Objetivo: apresentar um caso de lesão vascular em paciente idoso tratado pela técnica da escleroterapia. Relato do caso: paciente masculino, 67 anos, vítima de acidente vascular cerebral, buscou atendimento odontológico por apresentar raízes residuais. Durante o exame físico foi identificada lesão exofítica, de coloração violácea, base séssil, com aproximadamente dois centímetros, localizada em comissura labial esquerda. Para confirmar a origem da alteração foi realizada manobra semiotécnica (diascopia) que revelou tratar-se de lesão vascular. Por ser o paciente idoso, hipertenso, com histórico de acidente vascular cerebral, foi feita a opção por tratamento conservador, sendo realizada a escleroterapia com oleato de monoetanolamina 5%, numa única sessão. No retorno de sete dias, foi observada regressão parcial da lesão e com 30 dias a região se mostrou completamente cicatrizada, sem vestígios da alteração. O oleato de monoetanolamina provoca uma reação inflamatória estéril, aguda, dose-dependente, no endotélio vascular e nos tecidos extravasculares que resulta em fibrose e obliteração dos vasos sanguíneos, induzindo a regressão das lesões. Conclusão: Com base no caso apresentado e nos registros da literatura é possível afirmar que a escleroterapia é uma alternativa terapêutica minimamente invasiva, eficaz, de baixo custo e com resultado estético favorável no tratamento de lesões vasculares orais... (AU)
Objective: to present a case of vascular injury in an elderly patient treated by the sclerotherapy technique. Case report: male patient, 67 years old, victim of a stroke, sought dental care due to residual dental roots. During the physical examination, an exophytic lesion, violet in color, sessile base, approximately two centimeters, located in the left labial commissure, was identified. Diascopy was performed to confirm the origin of the alteration, which revealed that it was a vascular le sion. As the patient was elderly, hypertensive, with a history of stroke, conservative treatment was chosen, with sclerotherapy with 5% mon oethanolamine oleate in a single session. On return after seven days, partial regression of the lesion was observed and, after 30 days, the region was completely healed, with no traces of the alteration. Mon oethanolamine oleate causes a sterile, acute, dose-dependent inflam matory reaction in the vascular endothelium and extravascular tissues that results in fibrosis and obliteration of blood vessels, inducing re gression of the lesions. Conclusion: Based on the case presented and on the literature records, it is possible to affirm that sclerotherapy is a minimally invasive, effective, low-cost therapeutic alternative with a favorable aesthetic result in the treatment of oral vascular lesions... (AU)
Objetivo: presentar un caso de lesión vascular en un paciente de edad avanzada, tratado mediante la técnica de escleroterapia. Reporte de caso: paciente masculino, 67 años, víctima de un derrame cerebral, buscó atención odontológica por raíces dentarias residuales. Durante el examen físico se identificó una lesión exofítica, de color violeta, de base sésil, de aproximadamente dos centímetros, ubicada en la comisura labial izquierda. Se realizó diascopia para confirmar el origen de la alteración, que reveló que se trataba de una lesión vascular. Como el paciente era anciano, hipertenso, con antecedentes de ictus, se optó por tratamiento conservador, con escleroterapia con oleato de monoetanolamina al 5% en una sola sesión. Al regreso a los siete días se observó una regresión parcial de la lesión y, a los 30 días, la región estaba completamente curada, sin rastros de la alteración. El oleato de monoetanolamina provoca una reacción inflamatoria estéril, aguda y dependiente de la dosis en el endotelio vascular y los tejidos extravasculares que produce fibrosis y obliteración de los vasos sanguíneos, lo que induce la regresión de las lesiones. Conclusión: Con base en el caso presentado y en los registros de la literatura, es posible afirmar que la escleroterapia es una alternativa terapéutica mínimamente invasiva, efectiva, de bajo costo y con resultado estético favorable en el tratamiento de las lesiones vasculares orales... (AU)
Humans , Male , Aged , Sclerotherapy , Dental Care , Vascular Malformations , Hemangioma , Mouth/pathology , Blood Vessels , Vascular System Injuries , Conservative Treatment
Although ultrasound-guided interventional procedures have resulted in great advances in many fields of medicine, this approach has revolutionized endovascular procedures. This paper aims to review the basic principles to develop a strategy to follow in ultrasound-guided treatments of varices in the lower limbs, as well as to provide a brief overview of the main endovenous techniques available nowadays. We divide these techniques into those that use catheters to occlude straight saphenous axes (thermal / non-thermal ablation) and other options, such as foam sclerotherapy, which can be used in all types of varices, even in those originating in the pelvis.
Varicose Veins , Venous Insufficiency , Humans , Radiology, Interventional , Saphenous Vein/diagnostic imaging , Saphenous Vein/surgery , Ultrasonography, Interventional , Varicose Veins/surgery , Varicose Veins/therapy , Venous Insufficiency/therapy
Si en muchos campos de la medicina el intervencionismo ecográfico ha aportado grandes avances, sin duda en lo que respecta a las terapias endovenosas ha supuesto una revolución. El presente artículo pretende repasar los principios básicos para desarrollar una estrategia a seguir en los tratamientos ecoguiados de varices en los miembros inferiores. Así mismo, busca transmitir una breve perspectiva sobre las principales técnicas endovenosas disponibles en la actualidad. Dichas técnicas las dividiremos principalmente en aquellas que se sirven de un catéter con el fin de ocluir los ejes safenos rectos (ablación térmica/no térmica) y aquellas otras opciones, como es la esclerosis con espuma, que permite su uso en todo tipo de varices, incluso las de origen pélvico.(AU)
Although ultrasound-guided interventional procedures have resulted in great advances in many fields of medicine, this approach has revolutionized endovascular procedures. This paper aims to review the basic principles to develop a strategy to follow in ultrasound-guided treatments of varices in the lower limbs, as well as to provide a brief overview of the main endovenous techniques available nowadays. We divide these techniques into those that use catheters to occlude straight saphenous axes (thermal / non-thermal ablation) and other options, such as foam sclerotherapy, which can be used in all types of varices, even in those originating in the pelvis.(AU)
Humans , Ultrasonography , Varicose Veins , Venous Insufficiency , Sclerotherapy , Lower Extremity/diagnostic imaging , Radiology , Quality of Life
Introducción. Los linfangiomas son anormalidades benignas del sistema linfático, que corresponden a dilataciones quísticas de estos vasos y se localizan especialmente en el cuello. Solo el 10 % de todas estas malformaciones se encuentran en el abdomen y presentan síntomas variables de acuerdo al tamaño y su ubicación especifica, siendo el dolor abdominal el principal síntoma. Métodos. Se presentan cinco pacientes pediátricos con malformaciones linfáticas abdominales. Se describen su cuadro clínico, localización, tratamiento y la experiencia en el manejo de dicha patología en un hospital de referencia. Resultados. Los métodos más apropiados para hacer una aproximación diagnóstica son la ecografía, la tomografía computarizada y la resonancia nuclear magnética. Dentro de las opciones descritas para el tratamiento están la farmacológica, la escleroterapia y la resección quirúrgica, tanto por vía abierta como por laparoscopia. Conclusión. Existe una variedad de métodos para realizar la resección de los linfangiomas abdominales, pero la cirugía sigue siendo la más efectiva, especialmente cuando se cuenta con la laparoscopia como una herramienta terapéutica.
Introduction. Lymphangiomas are benign abnormalities of the lymphatic system, which correspond to cystic dilations of these vessels and are located especially in the neck. Only 10% of all these malformations are found in the abdomen and present variable symptoms according to size and their specific location, with abdominal pain being the main symptom. Methods. Five pediatric patients with abdominal lymphatic malformations are presented. Their clinical presentation, location, treatment and experience in the management of this pathology in a referral hospital are described. Results. The most appropriate methods to make a diagnostic approach are ultrasound, computed tomography and magnetic resonance imaging. Among the options described for treatment are pharmacological, sclerotherapy and surgical resection, both open and laparoscopic. Conclusion. There are a variety of methods for resecting abdominal lymphangiomas, but surgery remains the most effective, especially when laparoscopy is used as a therapeutic tool.
Humans , Lymphangioma , Lymphatic Diseases , Sclerotherapy , Laparoscopy , Lymphatic System
INTRODUCCIÓN. Los linfangiomas son una malformación infrecuente a escala mundial y constituye una preocupación para los padres del infante; está asociado a problemas estéticos y a posibles efectos deletéreos debido a la obstrucción o compresión de órganos vitales. Se ha descrito a la escleroterapia como la mejor opción de tratamiento. OBJETIVO. Determinar la eficiencia del tratamiento con bleomicina en linfangiomas en la población pediátrica de 0 a 18 años. MATERIALES Y MÉTODOS. Estudio transversal analítico retrospectivo. Población y muestra conocida de 20 datos de Historias Clínicas electrónicas de pacientes diagnosticados con linfangiomas y tratados con bleomicina en el Hospital de Especialidades Carlos Andrade Marín, desde enero 2015 a enero 2018. Criterios de inclusión: pacientes de 0 a 18 años de edad con diagnóstico de linfangioma mediante ecografía y angiotomografía computarizada. Criterios de exclusión: pacientes mayores de 18 años de edad o sospecha diagnóstica de linfangioma sin estudios de imagen, y/o que no acudieron a la cita de control, pacientes diagnosticados de linfangioma que no recibieron bleomicina para su tratamiento, niños con otras malformaciones vasculares. El análisis de datos se realizó en el programa estadístico International Business Machines Statistical Package for the Social Sciences. RESULTADOS. La mediana de edad en mujeres fue de 6,25 años y 3,8 años en hombres. 10 pacientes fueron hombres. El promedio de seguimiento fue de 26,86 +/- 16,78 meses. El tamaño promedio de los linfangiomas fue de 5,77 +/- 3,73 cm. La localización más frecuente fue cervical con un 52,38%. La mayoría fueron macronodulares con un 85,71%. La respuesta fue buena o excelente en el 81,00% de los casos con la primera infiltración y subió al 95,00% con la segunda y tercera, según requerimiento. CONCLUSIÓN. El tratamiento de los linfangiomas con bleomicina fue muy efectivo en la población estudiada.
INTRODUCTION. Lymphatic malformation is a rare malformation worldwide and is a concern for the parents of the infant; it is associated with aesthetic problems and possible deleterious effects due to obstruction or compression of vital organs. Sclerotherapy has been described as the best treatment option. OBJECTIVE. To determine the efficiency of bleomycin treatment in lymphangiomas in the pediatric population aged 0 to 18 years. MATERIALS AND METHODS. Retrospective analytical cross-sectional study. Population and known sample of 20 data from Electronic Medical Records of patients diagnosed with lymphangiomas and treated with bleomycin at the Carlos Andrade Marín Specialties Hospital, from January 2015 to January 2018. Inclusion criteria: patients aged 0 to 18 years with diagnosis of lymphangioma by ultrasound and computed angiotomography. Exclusion criteria: patients older than 18 years of age or diagnostic suspicion of lymphangioma without imaging studies, and/or who did not attend the control appointment, patients diagnosed with lymphangioma who did not receive bleomycin for treatment, children with other vascular malformations. Data analysis was performed in the statistical program International Business Machines Statistical Package for the Social Sciences. RESULTS. The median age in women was 6,25 years and 3,8 years in men. Ten patients were men. The average follow-up was 26,86 +/- 16,78 months. The average size of the lymphatic malformations was 5,77 +/- 3,73 cm. The most frequent location was cervical with 52,38%. Most were macronodular with 85,71%. The response was good or excellent in 81,00% of cases with the first infiltration and rose to 95,00% with the second and third, as required. CONCLUSION. The treatment of lymphangiomas with bleomycin was very effective in the population studied.
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Bleomycin/therapeutic use , Lower Extremity , Upper Extremity , Head and Neck Neoplasms/drug therapy , Lymphangioma/drug therapy , Antibiotics, Antineoplastic/therapeutic use , Axilla , Cross-Sectional Studies , Retrospective Studies , Treatment Outcome , Neck
Objetivo: una de las principales causas de las úlceras de los miembros inferiores es la enfermedad venosa. La compresión y la cirugía de safena han demostrado ser terapias efectivas para su tratamiento, con tasas similares de curación. La ablación endovenosa temprana ha confirmado que disminuye los tiempos de cicatrización y de recurrencia, pero el efecto de terapias simultáneas para el tratamiento del reflujo venoso sobre la cicatrización no está del todo demostrado. Métodos: se realizó un estudio descriptivo y retrospectivo de pacientes sometidos a radiofrecuencia y escleroterapia con espuma, guiadas por ecografía realizadas de manera simultánea como parte del tratamiento de úlcera venosa, y se describieron sus características sociodemográficas, clínicas y de evolución de la herida después de la intervención. Resultados: de las extremidades evaluadas, el 90,2 % (37) correspondía a mujeres, con una edad promedio de 65,8 años (± 12,5), el 56,1 % (23) procedentes de áreas rurales, con un tiempo de evolución de la herida de 18 meses (± 5-204) y un área de 20 cm2 (± 8-80). La tasa de curación fue del 61 % (25/41) a los 6 meses, con diferencias significativas en el área de la lesión antes de la intervención en el grupo que cicatrizó frente al que no lo logró (12 frente a 80 cm2, p < 0,001). Hubo mayor número de infecciones de piel y de tejidos blandos en el grupo que no cicatrizó (0 frente a 37,5 %, p < 0,001), una tasa de recurrencia del 4 % (1/25) y ninguna hospitalización relacionada con la enfermedad venosa. Conclusión: en la población evaluada, la ablación con radiofrecuencia y escleroterapia con espuma guiadas por ecografía, realizadas simultáneamente, hubo mayor cierre en las heridas de menor área con respecto a las de mayor área, así como un mayor número de infecciones de piel y de tejidos blandos en las extremidades que no cicatrizaron. No encontramos hospitalizaciones relacionadas con la evolución de la úlcera y hubo baja tasa de recurrencia.(AU)
Objective: lower limb ulcers are mainly caused by venous disease. Saphenous compression and surgery have been shown to be effective therapies for its treatment, with similar cure rates. Early endovenous ablation has been confirmed to increase healing and decrease recurrence times, but the effect of simultaneous therapies for the treatment of venous reflux on healing is not fully determined. Methods: a descriptive, retrospective study of patients undergoing radiofrequency and ultrasound-guided foam sclerotherapy performed simultaneously as part of venous ulcer treatment was carried out, and their sociodemographic and clinical characteristics and post-intervention wound evolution were described. Results: of the extremities evaluated, 90.2 % (37) corresponded to women, with an average age of 65.8 years (± 12.5), 56.1 % (23) from rural areas, with a wound evolution time of 18 months (± 5- 204) and an area of 20 cm2 (± 8-80). The cure rate was 61 % (25/41) at 6 months, with significant differences in the area of the lesion before the intervention in the group that closed vs. the one that did not close (12 vs. 80 cm2, p < 0.001). A higher number of skin and soft tissue infections was found in the group that did not heal (0 vs. 37.5 %, p < 0.001), a recurrence rate of 4 % (1/25), and no hospitalization related to venous disease. Conclusion: in the population evaluated, radiofrequency ablation and ultrasound-guided foam sclerotherapy was performed simultaneously, there was greater closure in wounds with a smaller area compared to those with a larger area, a greater number of skin and soft tissue infections in the extremities that did not heal, without hospitalizations related to the evolution of the ulcer and a low rate of recurrence.(AU)
Humans , Male , Female , Middle Aged , Aged , Radiofrequency Ablation , Sclerotherapy , Varicose Ulcer/drug therapy , Longitudinal Studies , Epidemiology, Descriptive , Retrospective Studies
Introducción: El linfangioma quístico es un tumor benigno infrecuente del sistema linfático que afecta habitualmente a los infantes. La opción terapéutica ideal es la extirpación quirúrgica. Objetivo: Sistematizar contenidos esenciales relacionados con el diagnóstico y tratamiento del linfangioma quístico. Métodos: Se realizó la búsqueda y el análisis de la información en un período de 10 años (2010-2020). Se emplearon las palabras clave: "linfangioma quístico" y "malformación linfática congénita quística", en español e inglés. Se hizo la revisión bibliográfica en un total de 62 artículos publicados en las bases de datos y bibliotecas electrónicas científicas de la salud: PubMed, Google Académico, Pubmed, Medline, Biblioteca Virtual en Salud, LILACS y SciELO, mediante el gestor de búsqueda y administrador de referencias EndNote; de ellos se seleccionaron 50 relevantes para el objetivo de la revisión. Resultados: La información se estructuró en los siguientes aspectos: sinonimia y antecedentes históricos, epidemiología, clasificación, patogenia, bases esenciales para el diagnóstico, tratamiento, complicaciones y pronóstico. Se identificaron controversias en cuanto a la terapéutica, y se mostraron las imágenes de los infantes diagnosticados y tratados por la autora en su colaboración médica en Angola en 2018. Conclusiones: Se sistematizan las bases esenciales para el diagnóstico y tratamiento del linfangioma quístico para que el cirujano general que, en su desempeño profesional, brinda asistencia médico quirúrgica a infantes fuera de Cuba, se empodere de las especificidades de este tumor linfático. También se revela como factible su resección quirúrgica íntegra para evitar recidivas, discapacidad y mejorar la calidad de vida del afectado(AU)
Introduction: Cystic lymphangioma is a rare benign tumor of the lymphatic system that usually affects infants. The ideal therapeutic option is surgical removal. Objective: Systematize essential contents related to the diagnosis and treatment of cystic lymphangioma. Methods: The search and analysis of information was carried out over a period of 10 years (2010-2020). The keywords "cystic lymphangioma" and "cystic congenital lymphatic malformation" were used in Spanish and English. The bibliographical review was carried out in a total of 62 articles published in the databases and electronic scientific health libraries: PubMed, Google Scholar, Pubmed, Medline, Virtual Library in Health, LILACS and SciELO, through the search and reference manager called EndNote; of these, 50 that were important to the objective of the review were selected. Results: The information was structured in the following aspects: synonym and historical backgrounds, epidemiology, classification, pathogenesis, essential bases for diagnosis, treatment, complications and prognosis. Therapeutic disputes were identified, and images of infants diagnosed and treated by the author in her medical collaboration in Angola in 2018 were shown. Conclusions: The essential bases for the diagnosis and treatment of cystic lymphangioma are systematized, so that the general surgeon who, in his-her professional performance, provides surgical medical assistance to infants outside Cuba is informed on the specificities of this lymphatic tumor. Its full surgical resection is also revealed as feasible to prevent recurrence, disability and to improve the quality of life of the affected person(AU)
Humans , Infant , Lymphangioma, Cystic/diagnosis , International Cooperation , Review Literature as Topic , Databases, Bibliographic , Libraries, Digital
ABSTRACT Objective: To evaluate the cure rate for dorsal synovial cysts of the wrist with aspiration and percutaneous sclerotherapy using 75% hypertonic glucose. Methods: We enrolled 45 patients older than 18 years with untreated dorsal synovial cysts of the wrist. They underwent percutaneous aspiration and sclerotherapy with 75% hypertonic glucose 75%. A maximum of two procedures were conducted for each cyst at a 4-week interval. We analyzed age, sex, affected side, history of previous trauma, wrist goniometry, grip strength, wrist pain by the visual analogue scale, complications, and hand function questionnaire scores. Results: We evaluated 45 patients (30 female, 15 male, mean age 38.2 years with 47 cysts). Four weeks after the first procedure, 72.3% cysts were palpable and visible. At 24 weeks after the first procedure, 57.4% cysts evolved to cure and 42.6% persisted. Conclusion: Treatment of dorsal synovial cyst of the wrist with aspiration and percutaneous sclerotherapy using 75% hypertonic glucose achieved a 57.4% cure rate after 24 weeks. Level of Evidence IV, Case series
RESUMO Objetivo: Avaliar o índice de cura do cisto sinovial dorsal do punho, com aspiração e escleroterapia percutânea utilizando glicose hipertônica 75%. Métodos: Foram selecionados pacientes maiores de 18 anos, portadores de cisto sinovial dorsal do punho, sem tratamento prévio. Foram submetidos a aspiração e escleroterapia percutânea com glicose hipertônica 75%. Foi realizado no máximo dois procedimentos em cada cisto, em um intervalo de 4 semanas. Foram analisados idade, gênero, lado acometido, história de trauma prévio, goniometria, força de preensão, dor no punho pela escala visual analógica, complicações e os escores dos questionários funcionais. Resultados: Foram avaliados 45 pacientes com 47 cistos, houve perda de seguimento de 3 pacientes (3 cistos). A média de idade foi de 38,2 anos. Na quarta semana após o primeiro procedimento, tivemos cura em 23,4% cistos, 4,3% cistos apresentavam-se palpáveis porém não visíveis e 72,3% cistos se apresentavam palpáveis e visíveis. Os cistos visíveis e palpáveis foram submetidos ao segundo procedimento. Após 24 semanas do primeiro procedimento, 57,4% cistos foram curados e 42,6% cistos apresentaram persistência. Conclusão: O tratamento do cisto sinovial dorsal do punho com escleroterapia percutânea utilizando Glicose Hipertônica 75%, proporcionou cura de 57,4% após 24 semanas. Nível de Evidência IV, Série de casos
Resumo Contexto A insuficiência venosa crônica é uma entidade com alta prevalência. Os casos avançados apresentam morbidade elevada. Objetivos Avaliar os riscos e benefícios da escleroterapia com espuma de polidocanol em pacientes que foram submetidos ao tratamento das veias safenas magnas bilateralmente em tempo único. Métodos Foram revistos retrospectivamente 55 pacientes (110 membros) portadores de incompetência bilateral das veias safenas magnas submetidas a tratamento escleroterápico com espuma bilateralmente, em tempo único, usando uma dose máxima de 20 mL de espuma de polidocanol por paciente. Resultados Das 110 safenas analisadas, obteve-se a oclusão de 81 (73,6%) com uma sessão, de 106 (96,3%) com duas sessões e de 110 (100%) com três sessões. Houve oclusão bilateral das safenas magnas em 27 pacientes (50%) em uma sessão, em 34 (62%) em duas sessões e em 55 (100%) em três sessões. De 11 pacientes portadores de úlceras, houve cicatrização total de sete (63%) e parcial de três (27%) 42 dias após a escleroterapia. Houve lipotimia autolimitada e escotomas visuais em um paciente (1,8%) e manchas em três (5,45%); 19 pacientes (34,5%) foram submetidos a punção para drenagem de coágulo retido. Conclusões A escleroterapia com espuma de polidocanol em veias safenas magnas em tempo único mostrou-se uma técnica segura e eficaz em pacientes selecionados.
Abstract Background Chronic venous insufficiency is a highly prevalent disease. Advanced cases have high morbidity. Objectives To evaluate the risks and benefits of foam sclerotherapy in patients who underwent bilateral treatment of the great saphenous veins in a single procedure, in selected cases of advanced venous insufficiency. Methods We retrospectively reviewed 55 patients (110 limbs) with bilateral incompetence of the great saphenous veins who had undergone foam sclerotherapy treatment bilaterally, using a maximum dose of 20 ml of foam per patient and inelastic compression. Results In 81 (73.6%) of the 110 saphenous veins analyzed, occlusion was obtained in the first session. After a second session this figure rose to 106 (96.3%) and all 110 (100%) veins were occluded after three sessions. Bilateral occlusion of the great saphenous veins was achieved in 27 patients (50%) in one session, in 34 (62%) patients in two sessions, and in 55 (100%) patients in three sessions. At 42 days after sclerotherapy, there was complete ulcer healing in seven (63%) of the 11 patients with ulcers and partial healing in 3 (27%) of these patients. One patient (1.8%) had self-limited lipothymia and visual scotomas, 3 patients (5.45%) had skin spots, and 19 patients (34.5%) developed retained intravascular coagulum. Conclusions Bilateral foam sclerotherapy in a synchronous procedure is an option to be considered for treatment of varicose veins of the lower limbs.
Humans , Male , Female , Adult , Middle Aged , Aged , Saphenous Vein/physiopathology , Sclerotherapy/instrumentation , Polidocanol/therapeutic use , Varicose Veins/therapy , Venous Insufficiency , Sclerotherapy/methods , Evaluation of Results of Therapeutic Interventions
Resumo As alterações vasculares ocorrem frequentemente em região de cabeça e pescoço, sendo o hemangioma a mais comum. Paciente do sexo feminino, 61 anos, queixou-se de dor intensa em palato duro. Notou-se lesão arroxeada, de 1,5 cm, sensível à palpação e com histórico de hemorragia. A paciente era edêntula total, e a prótese total superior comprimia o local da lesão. Foi realizada a vitropressão, confirmando a origem vascular. A hipótese diagnóstica foi de hemangioma. Na primeira sessão, aplicou-se o laser vermelho (660 nm) em quatro pontos ao redor da lesão, sendo 0,5 J em cada ponto afim de se obter analgesia e iniciar o processo de reparo, além do reembasamento da prótese total superior. Na segunda sessão, foi feita aplicação de 2 mL de oleato de monoetanolamina 5%. Após 14 dias, observou-se regressão total da lesão. Os cirurgiões-dentistas devem estar aptos a reconhecer, diagnosticar e tratar as lesões vasculares em cavidade oral.
Abstract Vascular changes frequently involve the head and neck region and hemagioma is the most common. A 61-year-old female patient complained of severe pain in the hard palate. A purple lesion was found, measuring 1.5 cm, sensitive to palpation, and with a history of hemorrhage. The patient was fully edentulous and her upper denture compressed the lesion site. Diascopy confirmed the lesion's vascular origin. A diagnostic hypothesis of hemangioma was raised. In the first session, red laser light (660nm) was applied at 4 points around the lesion, with 0.5 J at each point, in order to obtain analgesia and trigger the repair process. The upper denture was also relined. In the second session, 2 mL of 5% monoethanolamine oleate was applied. After 14 days, total regression of the lesion was observed. Dental surgeons must be able to recognize, diagnose and treat vascular lesions in the oral cavity.
Humans , Female , Middle Aged , Sclerotherapy/methods , Palate, Hard/injuries , Low-Level Light Therapy , Vascular System Injuries/therapy , Hemangioma/therapy , Mouth, Edentulous , Oral Medicine , Palate, Hard/blood supply , Denture, Complete, Upper , Hemangioma/diagnosis
Abstract Most patients with chronic venous disease (CVD) and reflux in the saphenous vein are treated with saphenous stripping or ablation. The venous hemodynamics approach offers the possibility of treating saphenous reflux without eliminating the saphenous vein. We present 2 cases in which venous reflux was eliminated while preserving the great saphenous vein, after treatment with hemodynamic sclerotherapy using a protocol of synergic use of Dextrose and long pulse Nd YAG 1064 laser. These cases show that treating the tributaries responsible for saphenous reflux can correct hemodynamic imbalances and restore normal flow in the great saphenous vein with improvements in symptoms and esthetics. Long-term results are still uncertain.
Resumo A maioria dos pacientes com insuficiência venosa crônica e refluxo na veia safena é tratada com retirada ou ablação da safena. A hemodinâmica venosa traz a possibilidade de tratar esses pacientes sem eliminar a veia safena. Nós apresentamos dois casos de refluxo parcial de veia safena magna resolvidos com escleroterapia hemodinâmica. Usamos um protocolo de uso sinergístico de glicose 75% e Nd-YAG laser 1064. Os casos nos mostram que o tratamento das tributárias pode corrigir o refluxo da veia safena e obter melhora clínica e cosmética. Os resultados de longo prazo ainda são incertos.
Humans , Female , Adult , Middle Aged , Venous Insufficiency/therapy , Sclerotherapy/methods , Saphenous Vein , Sclerotherapy/instrumentation , Hemodynamics , Lasers
Insuficiencia venosa es definida como la patología que causa síntomas en los miembros inferiores, incluyendo edema, hiperpigmentación, lipodermatoesclerosis y ulceración e implica una anormalidad funcional del sistema venoso. Objetivo: Se compararon los resultados en cuanto a complicaciones y satisfacción reportada por las pacientes, con la Escleroterapia con Polidocanol utilizando aire y agua como diluyente. Métodos: Se incluyeron en el estudio a 60 pacientes del sexo femenino con diagnóstico de Insuficiencia Venosa Superficial CEAP C1, divididas en dos grupos, a las cuales se les aplicó Escleroterapia con Polidocanol mezclado con agua y aire. Se realizó seguimiento durante cuatro semanas donde se recogió la información del paciente con respecto a la mejoría de los síntomas antes de iniciar el tratamiento y los efectos adversos del Polidocanol con ambas terapias. Resultados: Dentro de las complicaciones de ambos tratamientos únicamente fue reportado el Matting en rango leve durante la primera semana. El único síntoma reportado como severo fue Dolor en la escleroterapia con polidocanol mezclado con aire. Los demás signos síntomas fueron reportados dentro del rango de moderado el cual descendió hasta leve entre la segunda y tercera semana, no encontrando reportes a la cuarta semana. La única complicación reportada fue el Matting en la escleroterapia con polidocanol mezclado con aire. Conclusión: No se encontraron diferencias significativas en grado de satisfacción con la eficacia del tratamiento, los efectos adversos, la forma en que se administra el medicamento entre ambos tratamientos de escleroterapia, oscilando los rangos de satisfacción entre el 43 al 70%. (AU)
Venous insufficiency is defined as the pathology that causes symptoms in the lower limbs, including edema, hyperpigmentation, lipodermatosclerosis and ulceration and implies a functional abnormality of the venous system. Objective: The results in terms of complications and satisfaction reported by the patients were compared with Sclerotherapy with Polidocanol using air and water as diluent. Methods: 60 female patients with a diagnosis of Superficial Venous Insufficiency CEAP C1 were included in the study, divided into two groups, to which Sclerotherapy with Polidocanol mixed with water and air was applied. A follow-up was carried out for four weeks where information from the patient was collected regarding the improvement of symptoms before starting treatment and the adverse effects of Polidocanol with both therapies. Results: Within the complications of both treatments, only Matting was reported in a mild range during the first week. The only symptom reported as severe was pain in sclerotherapy with polidocanol mixed with air. The other signs and symptoms were reported within the moderate range, which decreased to mild between the second and third week, finding no reports at the fourth week. The only complication reported was Matting in sclerotherapy with polidocanol mixed with air. Conclusion: No significant differences were found in the degree of satisfaction with the efficacy of the treatment, the adverse effects, the way in which the drug is administered between both sclerotherapy treatments, the satisfaction ranges ranging from 43 to 70%. (AU)
Humans , Female , Sclerosing Solutions/therapeutic use , Venous Insufficiency/therapy , Sclerotherapy/methods , Polidocanol/therapeutic use , Sclerosing Solutions/adverse effects , Sclerotherapy/adverse effects , Treatment Outcome , Hyperpigmentation/chemically induced , Lower Extremity/blood supply , Polidocanol/adverse effects
ABSTRACT Objective: This study aim to evaluate the effectiveness of sclerotherapy protocols with different dilutions of ethanolamine oleate in the treatment of oral varicose veins. Methods: Clinical data and images of 14 cases treated with sclerotherapy were analyzed and descriptive analyses were performed. Results: Females (58%) and white skin color (83%) prevailed. Age varied between 14 and 79 years, with 47 years on mean (SD = 19 years). The most common anatomical locations were the buccal mucosa and lower lip. The final volume of the sclerosing agent (Ethamolin®) ranged from 0.4 to 4.3ml and the concentration ranged from 5% to 100%. The number of sessions ranged from 1 to 12 and the number of points per application was 1 to 7 points. Pain and edema were seen in 43% and 29% of patients, respectively. Conclusion: Sclerotherapy with monoethanolamine oleate diluted in anesthetic is a safe and effective option for the treatment of this lesion, regardless of concentration. However, edema and pain seem to be directly associated with increased drug concentration.
RESUMO Objetivos: Este estudo tem como objetivo avaliar a efetividade de protocolos de escleroterapia com diferentes diluições de oleato de etanolamina no tratamento de varizes orais. Métodos: Dados clínicos e imagens de 14 casos tratados com escleroterapia foram avaliados, sendo realizado análises descritivas. Resultados: As mulheres (58%) e a cor de pele branca (83%) prevaleceram na amostra. A idade variou entre 14 e 79 anos, com média de 47 anos (DP = 19 anos). As localizações anatômicas mais comuns foram a mucosa jugal e o lábio inferior. O volume final do agente esclerosante (Ethamolin®) variou de 0,4 a 4,3ml e a concentração variou de 5% a 100%. O número de sessões variou de 1 a 12 e o número de pontos por aplicação foi de 1 a 7 pontos. Dor e edema foram observados em 43% e 29% dos pacientes, respectivamente. Conclusão: A escleroterapia com oleato de monoetanolamina diluído em anestésico é uma opção segura e eficaz para o tratamento das varizes orais, independentemente da concentração. No entanto, edema e dor parecem estar diretamente associados ao aumento da concentração do medicamento.
ABSTRACT Objective: To evaluate the outcomes and costs associated with surgery versus sclerotherapy as treatment of hydroceles. Methods: A total of 53 men consecutively treated for hydrocele at our organization, between December 2015 and June 2019, were retrospectively analyzed (39 with Jaboulay technique and 14 with sclerotherapy). All charts were reviewed, assessing clinical data, ultrasound findings, surgical data, and post-procedure outcomes. The hospital finance department calculated the cost of outpatient evaluation, complementary tests, supplies, drugs, and professionals' costs throughout all procedures. Results: The median age for both groups was similar (58 and 65 years old). Comorbidities were less frequent in the Surgery Group (20; 51%) than in the Sclerotherapy Group (14; 100%, p<0.05). The median length of hospital stay was 34.5±16.3 hours for the Surgery Group and 4 hours for the Sclerotherapy Group. The mean follow-up period was similar for both groups (85.4±114.8 days after surgery, and 60.9±80.1 days after sclerotherapy, p=0.467). No significant complications occurred in any patient. Success rates were 94.8% after surgery and 92.8% after sclerotherapy. The mean cost per patient was US$2,558.69 in the Surgery Group (Hydrocelectomy Group) and US$463.58 in the Sclerotherapy Group (p<0.0001). Costs directly related to in-hospital treatment procedures were significantly higher for surgery versus sclerotherapy (US$2,219.82±US$1,629.06 versus US$130.64±US$249.60; p<0.0001). Conclusion: Sclerotherapy is an excellent treatment option for idiopathic hydrocele as compared to traditional Jaboulay. It has a high success rate, low complication rates, fast discharge and patients return quicker to activities of daily living.
RESUMO Objetivo: Avaliar resultados e custos associados à cirurgia e à escleroterapia como tratamentos das hidroceles. Métodos: Foram tratados consecutivamente para hidrocele em nossa instituição 53 homens, entre dezembro de 2015 e junho de 2019, os quais foram analisados retrospectivamente (39 pela técnica de Jaboulay e 14 por escleroterapia). Todos os prontuários foram revisados, avaliando dados clínicos, achados de ultrassom, dados cirúrgicos e desfechos pós-procedimento. O departamento financeiro do hospital calculou o custo da avaliação ambulatorial, dos exames complementares, dos insumos, dos medicamentos e dos profissionais em todos os procedimentos. Resultados: A idade mediana foi semelhante nos dois grupos (58 e 65 anos). Comorbidades foram menos frequentes no Grupo Cirurgia (20; 51%) do que no Grupo Escleroterapia (14; 100%; p<0,05). O tempo mediano de internação hospitalar foi 34,5±16,3 horas para o Grupo Cirurgia e 4 horas para Grupo Escleroterapia. O período médio de seguimento foi semelhante nos dois grupos (85,4±114,8 dias após a cirurgia e 60,9±80,1 dias após escleroterapia; p=0,467). Nenhuma complicação significativa ocorreu nos pacientes. As taxas de sucesso foram de 94,8% após a cirurgia e 92,8% após a escleroterapia. O custo médio por paciente foi de US$2,558.69 para Grupo Cirurgia e US$463.58 para Grupo Escleroterapia (p<0,0001). Os custos relacionados aos procedimentos de tratamento hospitalar foram significativamente maiores para cirurgia em relação à escleroterapia (US$2,219.82±US$1,629.06 versus US$130.64±US$249.60; p<0,0001). Conclusão: A escleroterapia é uma excelente opção de tratamento para hidrocele idiopática em comparação com a tradicional Jaboulay. Apresenta alta taxa de sucesso, baixas taxas de complicações e alta rápida, além de os pacientes retornarem mais rapidamente às atividades diárias.
Humans , Male , Aged , Sclerotherapy , Testicular Hydrocele/therapy , Activities of Daily Living , Retrospective Studies , Length of Stay , Middle Aged
